Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Betina T. Blak"'
Autor:
Sankarasubramanian Rajaram, Witold Wiecek, Richard Lawson, Betina T Blak, Yanli Zhao, Judith Hackett, Robert Brody, Vishal Patel, Billy Amzal
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0186739 (2017)
INTRODUCTION:During the 2013-2014 influenza season, Public Health England extended routine influenza vaccination to all 2- and 3-year-old children in England. To estimate the impact of this change in policy on influenza-related morbidity and mortalit
Externí odkaz:
https://doaj.org/article/8b4707f4b707451f8aaa805cc578d72a
Autor:
Shun Kohsaka, Carolyn S P Lam, Dae Jung Kim, Matthew A Cavender, Anna Norhammar, Marit E Jørgensen, Kåre I Birkeland, Reinhard W Holl, Josep Franch-Nadal, Navdeep Tangri, Jonathan E Shaw, Jenni Ilomäki, Avraham Karasik, Su-Yen Goh, Chern-En Chiang, Marcus Thuresson, Hungta Chen, Eric Wittbrodt, Johan Bodegård, Filip Surmont, Peter Fenici, Mikhail Kosiborod, John P Wilding, Kamlesh Khunti, Kåre Birkeland, Marit Eika Jørgensen, Reinhard W. Holl, Carolyn SP Lam, Hanne Løvdal Gulseth, Bendix Carstensen, Esther Bollow, Luis Alberto García Rodríguez, Jonathan Shaw, Suzanne Arnold, Betina T. Blak, Eric T. Wittbrodt, Matthias Saathoff, Yusuke Noguchi, Donna Tan, Maro Williams, Hye Won Lee, Maya Greenbloom, Oksana Kaidanovich-Beilin, Khung Keong Yeo, Yong Mong Bee, Joan Khoo, Agnes Koong, Yee How Lau, Fei Gao, Wee Boon Tan, Hanis Abdul Kadir, Kyoung Hwa Ha, Jinhee Lee, Gabriel Chodick, Cheli Melzer-Cohen, Reid Whitlock, Lucia Cea-Soriano, Oscar Fernándex Cantero, Jordan A. Menzin, Matthew Guthrie, Jennie Ilomaki, Dianna Magliano
Publikováno v:
Kohsaka, S, Lam, C S P, Kim, D J, Cavender, M A, Norhammar, A, Jørgensen, M E, Birkeland, K, Holl, R W, Franch-Nadal, J, Tangri, N, Shaw, J, Ilomäki, J, Karasik, A, Goh, S Y, Chiang, C E, Thuresson, M, Chen, H, Wittbrodt, E, Bodegård, J, Surmont, F, Fenici, P & Kosiborod, M 2020, ' Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors : an analysis from the CVD-REAL 2 multinational cohort study ', The Lancet Diabetes and Endocrinology, vol. 8, no. 7, pp. 606-615 . https://doi.org/10.1016/S2213-8587(20)30130-3
Lancet Diabetes & Endocrinology, 8(7), 606-615. ELSEVIER SCIENCE INC
Lancet Diabetes & Endocrinology, 8(7), 606-615. ELSEVIER SCIENCE INC
Background: Cardiovascular outcome trials have shown cardiovascular benefit with sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients with type 2 diabetes, whereas dipeptidyl peptidase-4 (DPP-4) inhibitors have not shown an effect. We aimed
Autor:
Mikhail Kosiborod, Carolyn S.P. Lam, Shun Kohsaka, Dae Jung Kim, Avraham Karasik, Jonathan Shaw, Navdeep Tangri, Su-Yen Goh, Marcus Thuresson, Hungta Chen, Filip Surmont, Niklas Hammar, Peter Fenici, Matthew A. Cavender, Alex Z. Fu, John P. Wilding, Kamlesh Khunti, Anna Norhammar, Kåre Birkeland, Marit Eika Jørgensen, Reinhard W. Holl, Carolyn SP Lam, Hanne Løvdal Gulseth, Bendix Carstensen, Esther Bollow, Josep Franch-Nadal, Luis Alberto García Rodríguez, Suzanne Arnold, Johan Bodegård, Kyle Nahrebne, Betina T. Blak, Eric T. Wittbrodt, Matthias Saathoff, Yusuke Noguchi, Donna Tan, Maro Williams, Hye Won Lee, Maya Greenbloom, Oksana Kaidanovich-Beilin, Khung Keong Yeo, Yong Mong Bee, Joan Khoo, Agnes Koong, Yee How Lau, Fei Gao, Wee Boon Tan, Hanis Abdul Kadir, Kyoung Hwa Ha, Jinhee Lee, Gabriel Chodick, Cheli Melzer Cohen, Reid Whitlock, Lucia Cea Soriano, Oscar Fernándex Cantero, Ellen Riehle, Jennie Ilomaki, Dianna Magliano
Publikováno v:
Journal of the American College of Cardiology. 71:2628-2639
Background Randomized trials demonstrated a lower risk of cardiovascular (CV) events with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes (T2D) at high...
Autor:
Matthew A. Cavender, Anna Norhammar, Kåre I. Birkeland, Marit Eika Jørgensen, John P. Wilding, Kamlesh Khunti, Alex Z. Fu, Johan Bodegård, Betina T. Blak, Eric Wittbrodt, Marcus Thuresson, Peter Fenici, Niklas Hammar, Mikhail Kosiborod, Kåre I Birkeland, Reinhard W. Holl, Hungta Chen, Eric T. Wittbrodt, Markus F Scheerer, Filip Surmont, Kyle Nahrebne, Hanne Løvdal Gulseth, Bendix Carstensen, Esther Bollow, Luis Alberto García Rodríguez, Lucia Cea Soriano, Oscar Fernándex Cantero, Ellen Thiel, Brian Murphy
Publikováno v:
Journal of the American College of Cardiology. 71:2497-2506
Background Prior studies found patients treated with sodium-glucose co-transporter-2 inhibitors (SGLT-2i) had lower rates of death and heart failure (HF). Whether the benefits of SGLT-2i vary based upon the presence of cardiovascular disease (CVD) is
Autor:
Billy Amzal, Betina T. Blak, Sankarasubramanian Rajaram, Robert Brody, Vishal Patel, Judith Hackett, Yanli Zhao, Richard Lawson, Witold Więcek, Tehseen Salimi
Publikováno v:
Human Vaccines & Immunotherapeutics
This study set out to evaluate influenza- and respiratory-related illnesses recorded during primary care physician consultations in England following the H1N1 pandemic in 2009 and to enable the development of a dynamic disease model. Data were obtain
Publikováno v:
PRIMARY CARE DIABETES
To investigate prescribing patterns and effect of dapagliflozin among individuals with T2DM using UK primary care data.Adult patients with T2DM initiating dapagliflozin treatment were identified from the Clinical Practice Research Datalink. Changes i
Autor:
R. Morlock, Betina T. Blak, Andrew Maguire, Victoria Parsons, Alyssa B Klein, Lewis Carpenter, Austin G. Stack, Michelle E. Johnson
Publikováno v:
BMJ Open, Vol 9, Iss 8 (2019)
BMJ Open
BMJ Open
ObjectiveEvaluate the association between gout and risk of advanced chronic kidney disease (CKD).DesignRetrospective matched cohort study.SettingUK Clinical Practice Research Datalink.ParticipantsThe analysis included data for 68 897 patients with go
Publikováno v:
Diabetes Therapy
DIABETES THERAPY
DIABETES THERAPY
Introduction The present study aimed to describe characteristics of patients with type 2 diabetes (T2D) in UK primary care initiated on dapagliflozin, post-dapagliflozin changes in glycated hemoglobin (HbA1c), body weight and blood pressure, and reas
Publikováno v:
Diabetes. 67
Early treatment intensification in patients with type 2 diabetes (T2D) is often required to achieve glycaemic control. Patients with T2D from the UK Clinical Practice Research Datalink, aged ≥18 years, initiating dapagliflozin between Nov 2012 and
Autor:
JP Wilding, Eric Wittbrodt, Marit E. Jørgensen, Niklas Hammar, Peter Fenici, Betina T. Blak, Alex Z. Fu, A Norhammar, Matthew A. Cavender, Mikhail Kosiborod, M Rodrigues Costa, Kamlesh Khunti, Kåre I. Birkeland, M Thuresson, Johan Bodegard
Publikováno v:
Diabetologie und Stoffwechsel.